[144] ANI Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for ANI Pharmaceuticals, Inc. (ANIP) reports a proposed sale of 5,421 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $486,406.81. The filing states the shares represent restricted stock acquired in two grants: 5,000 shares on 03/23/2022 and 421 shares on 08/05/2022, with corresponding payment dates matching acquisition dates. The sale is approximately dated 08/20/2025 and listed for execution on NASDAQ. The filer certifies they are not aware of undisclosed material adverse information about the issuer. No securities of the issuer were reported sold by the filer in the past three months.

Positive

• Filer complied with Rule 144 notification requirements by disclosing the proposed sale and acquisition details
• Sale size is small relative to the issuer's 21,688,772 shares outstanding, reducing likelihood of market impact

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine insider sale notice under Rule 144 for 5,421 restricted shares, appears procedural and compliant.

The filing documents a proposed sale of 5,421 restricted common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $486,406.81, to be executed on NASDAQ on or about 08/20/2025. Acquisition records show two restricted stock grants from the issuer dated 03/23/2022 and 08/05/2022 that total the shares offered. The notice includes the standard representation that the seller lacks undisclosed material information. This filing fulfils the Rule 144 notification requirement and contains no disclosure of unusual terms, partial payments, or prior sales in the last three months, suggesting routine compliance activity rather than a material corporate development.

Equity Market Analyst

TL;DR: Insider intends to sell a modest number of shares relative to outstanding float; unlikely to be market-moving.

The proposed sale of 5,421 shares represents a small fraction of the reported 21,688,772 shares outstanding. With an aggregate value under $500k and no recent sales reported by the filer, this transaction is unlikely to materially affect liquidity or market pricing for ANIP. The filing provides acquisition dates and indicates restricted stock origin, which explains the use of Rule 144 to clear resale conditions. No additional company operational or financial information is disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5421	486406.81	21688772	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2022	Restricted Stock	Issuer			421	08/05/2022	Not Applicable
Common	03/23/2022	Restricted Stock	Issuer			5000	03/23/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ANIP Form 144 report?

The filing reports a proposed sale of 5,421 common shares of ANI Pharmaceuticals (ANIP) valued at $486,406.81, to be executed about 08/20/2025 on NASDAQ.

Who is the broker handling the sale?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

When were the shares acquired that are being sold?

Shares were acquired as restricted stock on 03/23/2022 (5,000 shares) and 08/05/2022 (421 shares).

Has the filer sold other ANIP securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing disclose any undisclosed material information about ANIP?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.